VISUAL ABSTRACTViola
D
uchenne muscular dystrophy (DMD) is a fatal X-linked disease that affects 1 in 3,600 to 6,000 live male births (1, 2) . It is caused by a lack of expression of dystrophin, an important cytoskeletal protein that plays a role in maintaining structural integrity in muscle cells (3) . DMD patients exhibit muscle degeneration primarily in skeletal muscles (2) . However, in addition to this, patients develop dilated cardiomyopathy that is associated with cytoskeletal protein disarray, contractile dysfunction, and reduced myocardial metabolic activity (4, 5) .
Approximately 20% of DMD patient deaths result from dilated cardiomyopathy (6) .
Approximately 70% of DMD-causing mutations are located between exons 45 and 55 (7) . The effect of several therapeutic approaches on DMD cardiac pathology have been investigated, with varying degrees of efficacy reported (8) (11, 12) . Myocytes isolated from mdx mice that exhibit cytoskeletal disarray due to the absence of dystrophin, exhibit impaired I Ca-L regulation of mitochondrial function (11) . Importantly, this lack of response occurs in both pre-and post-cardiomyopathic mdx mice, suggesting that metabolic dysfunction precedes development of the cardiomyopathy (11) .
We have previously shown that long-term, low-dose treatment of pre-cardiomyopathic mdx mice with an antisense oligomer of the same PMO chemistry administered clinically to DMD patients (13) , partially restores mitochondrial function of the heart. Cells were isolated based on methods described (11, 18) . Detailed methods are provided in the Supplemental Methods.
FLUORESCENT STUDIES. All studies were performed in intact mouse cardiac myocytes at 37 C. was used to measure mitochondrial membrane potential (J m ) as described previously (19) . Flavoprotein autofluorescence was used to measure flavoprotein oxidation based on previously described methods (20, 21) . Detailed methods are provided in the Supplemental Methods.
The rate of cleavage of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide to formazan by the mitochondrial electron transport chain was measured spectrophotometrically as previously described (11, 12) . Each n represents the number of replicates for each treatment group from myocytes isolated from a total of 9 wt, 6 mdx, and 6 PMOtreated mdx hearts. Detailed methods are provided in the Supplemental Methods. 
Viola et al. We also examined the efficacy of a long-term, highdose PMO treatment regimen on restoring J m in isolated cardiac myocytes. Under calcium-free conditions, BayK(-) elicited a significant increase in J m NS ¼ not significant; Oligo, 20 mM oligomycin; -ve ¼ negative control; J m , mitochondrial membrane potential.
in wt myocytes that was attenuated with nisoldipine ( Figure 3B) . No alteration was observed in agematched mdx myocytes ( Figures 3A and 3B) . However, treatment of mdx mice with 40 mg/kg PMO 3Â per week for 19 weeks completely rescued this response ( Figures 3A and 3B) . The response was attenuated with nisoldipine ( Figure 3B ). BayK(þ) did not significantly alter J m in wt or mdx myocytes ( Figure 3B ).
Oligomycin induced a significant increase in JC-1 fluorescence in mdx myocytes demonstrating weeks; other abbreviations as in Figure 1 . We also investigated the efficacy of a long-term, high-dose PMO treatment regimen on metabolic activity. BayK(-) caused a significant increase in flavoprotein oxidation in myocytes from 43-week-old wt mice that was prevented with nisoldipine ( Figure 3D ).
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PMO Therapy to Prevent mdx Cardiomyopathy
No alteration was observed in age-matched mdx myocytes ( Figures 3C and 3D) . However, myocytes isolated from 43-week-old mdx mice treated with PMO exhibited a significant increase in flavoprotein in response to BayK(-) that was attenuated by nisoldipine ( Figures 3C and 3D) . BayK(þ) did not significantly alter flavoprotein oxidation in wt or mdx myocytes ( Figure 3D ). Carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone increased flavoprotein signal in all myocytes confirming the signal was mitochondrial in origin ( Figures 3C and 3D ). However, myocytes isolated from 43-week-old mdx mice treated with PMO exhibited a significant increase in metabolic activity in response to BayK(-) that could be attenuated by nisoldipine or Ru360, but not dantrolene ( Figures 4A and 4B) . BayK(þ) did not 
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Viola et al. Figure 1 . mg/kg for 12 weeks) versus placebo cohorts, but by week 49, the difference was no longer significant (27, 28) . A subsequent phase 3 double-blinded placebo-controlled study involving prolonged treatment of DMD patients with 6 mg/kg/week (48 weeks) did not improve ambulation (6-min walk test) or secondary assessments of motor function (29) .
Furthermore, adverse events including kidney and liver toxicity, likely to be off-target effects of the 2 0 Omethylated phosphorothioate backbone, were reported in 46% of patients (27, 28, 30) .
PMO consist of a 6-membered morpholine ring moiety, joined by phosphorodiamidate linkages.
Unlike phosphorothioates, the backbone carries no charge at physiological pH, reducing off-target effects (31) . PMO are nontoxic and stable (32) . 
